Arm function and quality of life after trimodal treatment of sulcus superior tumour (SST)
Recruiting
- Conditions
- Pancoast tumour1002910710038737
- Registration Number
- NL-OMON34727
- Lead Sponsor
- Heelkunde VUmc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Surgical resection of sulcus superior tumour in VUmc after induction treatment with chemoradiatiotherapy
Treated after 01-01-2002
Age at treatment between 18 and 80 years
Exclusion Criteria
Current functional status ECOG >2 (confined to bed or chair >50% of waking hours)
Armfunction not assessable due to causes unrelated to locoregional treatment for SST (e.g. CVA, trauma, brain metastasis)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Questionnaire DASH (Disability of Arm, Shoulder and Hand)<br /><br>Questionnaire Quality of life (SF-36)<br /><br><br /><br>Objective measurement of arm- and shoulderfunction (treated and untreated<br /><br>extremity)<br /><br>A.R.A.-test: Action research arm-test<br /><br>9-hole peg-test<br /><br>R.O.M.-test: Range Of Motion-test<br /><br>FAT-test: Frenchay Arm Test </p><br>
- Secondary Outcome Measures
Name Time Method <p>Age<br /><br>Symptomatic period before start treatment<br /><br>Radiotherapy dose<br /><br>chemotherapy scheme<br /><br>clinical tumour stage (cTNM)<br /><br>pathological tumour stage (pTNM)<br /><br>Time interval between induction and surgery<br /><br>Time interval between surgery and study date<br /><br>Right or left handedness</p><br>